Samuel George A. III

Samuel George A. III is listed in filings as General Counsel at Lineage Cell Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 6, 2026, including purchase activity. Recent filings connect the profile to Lineage Cell Therapeutics, Inc. (LCTX). The current snapshot covers public activity from Nov 26, 2024 to Mar 6, 2026. Reported amounts are shown as $9.0K to $397.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.